Repository Corticotropin in Treating De-Novo C3 Glomerulonephritis Post-Transplantation
Introduction: De-novo C3 glomerulonephritis (C3GN) post-transplant is uncommon. Although eculizumab has been used successfully in several cases, the response is heterogeneous and treatment strategies remain undefined. The use of repository corticotropin in C3GN has not been described in the literatu...
Guardado en:
Autores principales: | Muhammad Saad Naseer, Ayush Singh, Neeraj Singh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Karger Publishers
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/290bca6c394f4e81afb2c8d4c95e74a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunoglobulin-negative fibrillary glomerulonephritis masked in diabetic nephropathy: A case report and discussion of a diagnostic pitfall.
por: Gabriel B.W. Lerner, et al.
Publicado: (2021) -
Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase Alfa
por: Hajime Kato, et al.
Publicado: (2021) -
Maternal and Fetal Outcomes in Women with Diabetes in Pregnancy Treated before and after the Introduction of a Standardized Multidisciplinary Management Protocol
por: Maddalena Morlando, et al.
Publicado: (2021) -
Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
por: Reham Z. Hamza, et al.
Publicado: (2021) -
Shape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin
por: C Wright, et al.
Publicado: (2021)